GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » New Horizon Health Ltd (HKSE:06606) » Definitions » Net Income From Continuing Operations

New Horizon Health (HKSE:06606) Net Income From Continuing Operations : HK$120 Mil (TTM As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is New Horizon Health Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. New Horizon Health's net income from continuing operations for the six months ended in Jun. 2023 was HK$137 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Jun. 2023 was HK$120 Mil.

New Horizon Health Net Income From Continuing Operations Historical Data

The historical data trend for New Horizon Health's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

New Horizon Health Net Income From Continuing Operations Chart

New Horizon Health Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22
Net Income From Continuing Operations
-255.44 -118.21 -934.62 -3,777.89 -88.96

New Horizon Health Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Net Income From Continuing Operations Get a 7-Day Free Trial Premium Member Only -3,493.44 -236.97 -76.52 -16.79 137.10

New Horizon Health Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$120 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

New Horizon Health (HKSE:06606) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » New Horizon Health Ltd (HKSE:06606) » Definitions » Net Income From Continuing Operations
Comparable Companies
HKSE:01789 HKSE:09877 HKSE:02172 HKSE:02291 HKSE:01858 HKSE:01302 HKSE:02407 HKSE:09996 HKSE:06922 HKSE:02160 ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
6YZ:Germany
Address
400 Jiang’er Road, 13th Floor, T1 Building, Binjiang District, Zhejiang, Hangzhou, CHN, 310052
Website
https://ir.newhorizonbio.com
New Horizon Health Ltd is engaged in early cancer screening and in-home testing in China. The company has an early detection and cancer screening-focused pipeline of five products and product candidates with an emphasis on colorectal cancer screening. The company focuses on cancer prevention and cure through screening and early detection. It generates maximum revenue from ColoClear and Pupu Tube products.

New Horizon Health (HKSE:06606) Headlines

No Headlines